```
prompt_version: stage1-v16.1-20260414
```

[Turn 3: Agent V3]
field: Analytical chemistry / quantitative data reporting
field_rationale: Pre-emption check: V2 declared [preempts_turn3_default: no], and the guidance table recommendation (analytical chemistry / chromatography based on yield tables as primary evidence in S0-2/S0-4) is therefore available. V1 asked about what data are absent; V2 asked about mechanistic interpretation; V3 addresses the quality and reliability of the reported quantitative data — NMR yield calibration, single-point measurements, mass balance closure, and the analytical basis for isotopic incorporation values — none of which were covered by V1 or V2.

--- New questions ---

V3-Q1 | P2788:Lcol* | [REDACTED: substantial verbatim quotation; see Tier 9] | Was a response factor for dibenzyl ether validated against the product 3aa and starting material 1a? Does the polymeric PMHS reagent interfere with ¹H NMR integration regions used for yield calculation? The calibration protocol is referenced to SI but no validation data appear in the main text. | severity: medium | T1

V3-Q2 | P2789:Lcol* | "Yield determined after purification." [Figure 2 footnote] | For substrate scope entries, only isolated (purified) yields are reported. The crude NMR yield before purification is not given. For entries with moderate isolated yields, it is unclear whether low conversion, product instability during reaction, or losses during purification is the limiting factor. | severity: medium | T1

V3-Q3 | not recoverable | [absence of any replication statement in the substrate scope section] | All NMR and isolated yields are single-point measurements. No replicate experiments, no standard deviations, and no range indicators are reported for any entry. For a reaction that depends critically on the slow-addition rate of PMHS, the absence of replication data prevents any assessment of reproducibility. | severity: high | T1

V3-Q4 | P2788:Lcol* | [REDACTED: substantial verbatim quotation; see Tier 9] | 38 + 21 + 19 + 16 = 94%; 6% is unaccounted. Is this within experimental uncertainty of the NMR yield method, or does it represent uncharacterized byproducts? The completeness of the mass balance is relevant to the mechanistic claim that only two competing pathways operate. | severity: medium | T1

V3-Q5 | P2789:Rcol* | [REDACTED: substantial verbatim quotation; see Tier 9] | The deuterium incorporation values (0.8 D, 0.2 D, 0.9 D) are reported without describing the analytical method: was incorporation measured by ¹H NMR integration (requiring a defined relaxation delay and signal averaging), ²H NMR quantification, or mass spectrometry? Without stating the acquisition parameters, the precision of these isotope incorporation values is undefined. | severity: medium | T1

V3-Q6 | P2789:Lcol* | "Reaction time of 24 h." / "Reaction time of 48 h." [Figure 2 footnotes] | How was reaction completion determined for each substrate scope entry? The criterion for stopping the reaction (TLC, GC aliquot, NMR monitoring) is not described in the main text, making it unclear whether reactions run to full conversion or were stopped arbitrarily at 24 or 48 h. | severity: medium | T1

V3-Q7 | P2788:Lcol* | [REDACTED: substantial verbatim quotation; see Tier 9] | The dramatic yield improvement from slow addition (21% batch → 82–87% slow addition) depends on precise control of addition rate. The syringe pump settings, PMHS solution concentration, and needle specifications are referenced to SI (p S7) but absent from main text. How sensitive is yield to deviation from the prescribed addition rate? No robustness data is reported. | severity: high | T1

V3-Q8 | P2789:Lcol* | [REDACTED: substantial verbatim quotation; see Tier 9] | This comparative performance claim references prior work (refs 8–10, 15–20) without reproducing any specific yield, substrate, catalyst loading, or reaction time from those reports. The comparison cannot be evaluated without the referenced data. | severity: high | T1

--- Overlaps with V1/V2 ---

V3-OV1 | overlaps_with: V1-Q1 | severity_V3: high | note: From an analytical standpoint, the absence of mass balance data across the substrate scope is particularly significant because variable byproduct formation for different substrates would be completely invisible in the current reporting, making the scope table an incomplete representation of reaction performance.

V3-OV2 | overlaps_with: V1-Q15 | severity_V3: high | note: Single-point yield measurements are a systematic analytical deficiency; for a paper reporting a new reaction with a syringe-pump-dependent protocol, the absence of replicate data prevents assessment of whether the reported yields are typical or best-case results.

V3-OV3 | overlaps_with: V2-Q1 | severity_V3: medium | note: The precision implied by reporting 0.8 D (rather than ~80%) requires that the NMR integration was performed under quantitative conditions; without stating relaxation delay (typically ≥5×T1) and number of scans, the reported deuterium incorporation values carry undefined analytical uncertainty.
```

---

> **Tier 8 redaction notice**: This file is a redacted copy of the corresponding Tier 3 / Tier 9 output. Verbatim source-paper quotations have been replaced by `[REDACTED: see source paper §<loc>; full text retained in Tier 9 reviewer-only deposit]` markers, preserving location references and our own analytical content. Bibliographic fields (title, authors, journal, year, DOI), analytical labels (`evidence_chain:` with B-/U-/A-/C- internal IDs), short technical terms, and our own analytical text are not redacted. The redaction was applied by `scripts/redact_for_tier8.py` and, for this version, by `scripts/build_paperA_R1_public.py` with `scripts/redact_source_ngram_runs.py` (scripts of the project repository; they are not deposited).
